BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Alliance - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://hemoalliance.org
X-WR-CALDESC:Events for Hemophilia Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251030T140000
DTEND;TZID=America/New_York:20251030T150000
DTSTAMP:20260423T051348
CREATED:20250912T144235Z
LAST-MODIFIED:20250912T144438Z
UID:71524-1761832800-1761836400@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A Webinar From Novo Nordisk - Alhemo (concizumab-mtci): A new option for patients living with hemophilia
DESCRIPTION:Date: Thursday\, October 30th\, 2025\nTime: 2:00pm – 3:00pm ET \n \n  \n  \n  \n \nWEBINAR TOPIC: \nAlhemo (concizumab-mtci): A new option for patients living with hemophilia. \nOBJECTIVE: \nTo provide an update on prescribing information of the recently FDA-approved indication in patients with hemophilia A or B without inhibitors\, and supporting data from the explorer8 trial. \nAUDIENCE: \nAll HTC Staff. \nSPEAKER: \nRyan Rodriguez\, PharmD\, MS\, BCPS\, is a Medical Liaison for rare blood disorders at Novo Nordisk covering the Midwest. His responsibilities include learning from and sharing medical information with clinicians who treat patients with hemophilia and other bleeding disorders\, aligning with his passion for evidence-based patient care. \nPrior to joining Novo Nordisk\, Ryan earned his PharmD degree from the University of Florida\, and then served as Clinical Associate Professor at the University of Illinois Chicago College of Pharmacy\, where he also earned his Master’s degree in epidemiology. Throughout his career\, Ryan has been involved in medical communications\, evidence generation and publication\, and formulary management for various public and private entities.
URL:https://hemoalliance.org/alliance-events/a-webinar-from-novo-nordisk-alhemo-concizumab-mtci-a-new-option-for-patients-living-with-hemophilia/
CATEGORIES:Members Only,Webinar
END:VEVENT
END:VCALENDAR